InvestorsHub Logo
Followers 38
Posts 1440
Boards Moderated 0
Alias Born 03/07/2004

Re: Bungler post# 96798

Sunday, 09/30/2012 7:01:29 PM

Sunday, September 30, 2012 7:01:29 PM

Post# of 346146
If sitting on an FDA panel tomorrow voting on whether to send PPHM Bavi back to "Go", and someone showed you the studies on all-human Bavi MAB and prostate cancer, would recent events at Peregrine Pharm. make you look more/less carefully/favorably on a proposed fully humanized Bavi trial in prostate cancer? PPHM, Inc. reputation appears to me to be no worse than before the deluge one week ago. It appears that awareness and Bavi- (anti-PS MAB) technology is blooming. Lots of people love underdogs with a compelling story...and PPHM pipeline is a good one. Bavi- will one day be in the pioneering group of Avastin and ERbitux MABs, now grudgingly retiring from the field of battle. Does PPHM's Bavi have sumpin' special? Yes. It's no threat to existing treatment methods...supplements their action by helping the body clean out the death and debris caused by chemo-, irradiation, or surgery. Has the battle against solid tumors with MABs/immunomodulators moved forward as a result of efforts at PPHM? I think so.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News